Objective To assess whether rural–urban disparities exist in people with SLE for hospitalisation with myocardial infarction (MI). Methods We used the 2016–2019 US National Inpatient Sample data that ...
Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...
In this paper by Attar and colleagues (BMJ 2025;391:e083382, doi:10.1136/bmj-2024-083382, published 29 October 2025), The BMJ was alerted to post-publication ...
The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...
PHILADELPHIA, PA / ACCESS Newswire / November 3, 2025 / Prolocor, Inc., a healthcare startup developing the innovative diagnostic Prolocor pFCG TM test that identifies patients at higher and lower ...
The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month The Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback